Overview of Uvasal

Uvasal is an Over-The-Counter (OTC) pharmaceutical classified as an antacid specifically designed to provide rapid relief from symptoms caused by excess acid in the stomach. The product is physically presented as Effervescent Powder (Sales Efervescentes), which forms a Granules for Oral Solution intended for oral administration.

Quick Facts: Uvasal Identity

Property	Description
Active Ingredients	Sodium Bicarbonate, Citric Acid, Sodium Carbonate
Form	Effervescent Powder (Granules for Oral Solution)
Pharmacological Class	Antacid (ATC A02)
Common Use	Quick relief of acid indigestion, heartburn
Origin	Synthetic/Derived chemical entities

Uvasal: Definition, Class, and Pharmaceutical Form

Uvasal belongs to the pharmacological class of antacids (Antiácidos), which are chemical agents used to neutralize existing gastric acidity. This specific formulation is a recognized Combination Product that is clinically supported for its ability to provide symptomatic relief in cases of hyperacidity. The Effervescent Powder form is a unique characteristic of Uvasal, ensuring the active components are thoroughly dispersed in a solution, enabling rapid dissolution and immediate readiness for action within the digestive tract.

Composition and Chemical Structure

Uvasal is defined by its core active ingredients: Sodium Bicarbonate, Citric Acid, and Sodium Carbonate. These are derived, synthetic chemical entities engineered to work together. Sodium Bicarbonate is recognized as a systemic antacid that reduces stomach acid and is often used for the symptomatic relief of dyspepsia. The inclusion of Citric Acid is specific to the effervescence, setting this formula apart from non-fizzy bicarbonate products.

General Purpose and Action Principle

Uvasal's general purpose is to achieve rapid acid neutralization to alleviate acute discomfort related to excessive gastric acidity, such as sour stomach and heartburn. The alkaline ingredients directly encounter and chemically buffer the existing hydrochloric acid. The use of sodium bicarbonate in combination antacids provides immediate relief from heartburn by quickly neutralizing gastric acid. This principle of direct neutralization provides an immediate onset of action, quickly addressing the acute irritation caused by acid present in the upper digestive tract.

Regulatory References

What side effects are possible with Uvasal?

Possible Side Effects and Safety Information

The safety profile for Uvasal is based on the official regulatory documentation for its active ingredient, Sodium Bicarbonate, which acts as a systemic antacid. Adverse reactions primarily involve the gastrointestinal tract and the body's metabolic system.

Documented Adverse Reactions

Adverse effects commonly associated with this class of effervescent antacid relate to the release of gas. These are often categorized as Gastrointestinal Disorders and include belching, flatulence (gassiness), and abdominal distention.

More significant, but generally less frequent, effects fall under Metabolism and Nutrition Disorders and can include metabolic alkalosis, which is a systemic rise in the body's pH. Symptoms potentially related to alkalosis and electrolyte shifts may include irritability and tetany (muscle cramps). These metabolic risks are strongly associated with prolonged use or the consumption of large doses, not short-term, appropriate use.

Safety Considerations and Restrictions

Official labeling documents highlight safety considerations for specific patient populations, particularly due to the product's high sodium content. Caution is required for patients with pre-existing conditions that affect fluid and sodium balance, including congestive heart failure, hypertension (high blood pressure), severe renal insufficiency (kidney disease), and liver disease (cirrhosis).

Additionally, the product is generally restricted to occasional, short-term relief only. This duration-of-use constraint is a key regulatory safety measure designed to prevent the onset of serious metabolic complications, such as hypernatremia (high sodium levels) and the rare, serious condition known as Milk-Alkali Syndrome.

Overdose and Emergency Response

Overdose and when to seek help

Overdosage of Uvasal, due to the excessive systemic absorption of its active component, is formally documented to lead to Metabolic Alkalosis and Hypernatremia (high sodium levels). Officially documented overdose presentations include clinical manifestations such as headache, nausea, vomiting, increased thirst, and unusual weakness. More severe presentations include neurological signs like hyperirritability and muscle spasms known as tetany.

The regulatory profile highlights that overdosage carries a risk of life-threatening fluid and sodium overload complications. Patients with pre-existing conditions such as severe renal insufficiency or congestive heart failure are noted to have an increased risk of severe outcomes, including pulmonary oedema (fluid in the lungs).

Official guidance mandates that individuals must seek immediate medical attention by contacting a Poison Control Center or emergency services if overdose symptoms are severe, or if the affected person collapses, has trouble breathing, or has a seizure. Management procedures documented in regulatory labeling are symptomatic and supportive, focusing on correcting the acid-base and electrolyte imbalances. No specific antidote is known for this type of antacid overdose.

Therapeutic Uses of Uvasal

What Uvasal Treats: Main Uses and Benefits

Uvasal is a supportive formulation used to help address symptoms related to physical discomfort and conditions that benefit from changes to physiological acidity. Specifically, Uvasal helps address discomfort, such as heartburn, sour stomach, and acid indigestion, which may be part of symptomatic management for acidic issues. It is commonly used to help with symptoms presenting with systemic or localized discomfort arising from temporary acid imbalance.

The active compound is used as an antacid to relieve heartburn and acid indigestion. The compound is also considered relevant for conditions involving episodic or fluctuating manifestations where support for systemic or urinary acidity is needed.

Uvasal provides support that helps ease the overall symptom burden associated with discomfort from acid buildup or an overly acidic systemic state. The benefit is that it supports general well-being during symptomatic phases. The effervescent form assists with maintaining functional stability by providing an alternative to tablet consumption.

Quick Fact: Relief for Heartburn Uvasal is applied in scenarios where short-term symptomatic assistance is needed to help manage discomfort from acid indigestion.

Regulatory References

NIH MedlinePlus overview on Sodium Bicarbonate

Eligibility and Restrictions for Use

Uvasal's eligibility profile is strictly defined by regulatory authorities based on the medicine's sodium content and its alkalinizing effect. The medicine is primarily approved for use in adults under 60 years of age and adolescents 12 years and older for short-term, occasional administration, provided no absolute contraindications exist.

Population Status	Regulatory Classification
Contraindicated	Patients with severe renal insufficiency, severe heart failure, metabolic alkalosis, or signs of appendicitis or intestinal bleeding.
Conditional Use	Older adults (60 years and up) are subject to a restricted maximum daily dose. Pregnant and lactating individuals must use the medicine only under the advice and supervision of a health professional.

Eligibility is restricted for individuals with conditions sensitive to sodium, such as hypertension, pre-existing kidney or liver disease, or states of edema (swelling). Use is explicitly not recommended for children under 12 years of age unless prescribed by a physician. Furthermore, individuals on a sodium-restricted diet are contraindicated for use unless under medical direction.

What should I know about interactions with other medicines?

Uvasal Interactions with other medicines and products

Official regulatory documentation identifies clinically significant interactions involving both prescription drug classes and specific medicinal products, which are explicitly listed in the labeling. The interaction profile is structured around two main mechanistic categories: pharmacokinetic alterations, such as those affecting drug absorption due to changes in gastric pH or altered excretion, and pharmacodynamic effects, which can involve additive or opposing physiological actions.

Documented Interaction Categories

Category	Interaction Restriction/Constraint
Acid-Dependent Oral Medications	Timing separation required due to altered absorption (pharmacokinetic basis).
Certain Anticoagulant Agents	Enhanced monitoring required due to altered clinical effect.
Specific Diuretics/Corticosteroids	Use with caution due to risk of electrolyte imbalance (pharmacodynamic basis).
Laboratory/Diagnostic Procedures	Procedural constraints or clinical interpretation adjustments may be necessary.

Interactions that result in a contraindication or require a severe precaution are detailed in the official warnings, mandating that the combination be avoided or managed with rigorous clinical oversight. For many co-administered products, official labeling specifies a time interval requirement for administration to mitigate the effect on absorption. All clinically relevant interactions, including those with non-prescription products or foods, are documented to ensure the medicine's safe use.

Mechanism of Action

Direct Chemical Neutralization of Gastric Acid

Uvasal primarily acts through an acid-base reaction that targets the excess hydrochloric acid ( HCl) in the stomach lumen. The basic components rapidly engage the free H^+ ions, leading to a prompt reduction in the acid load. This direct chemical action rapidly converts the highly acidic environment into a more neutral one, which establishes the initial conditions for the observed physiological consequences.

Modulating Gastric pH and Enzyme Activity

The fast increase in pH not only reduces the acid load but also affects digestive enzyme activity, particularly that of pepsin. By raising the pH above the optimal range required by pepsin, the enzyme is inactivated, resulting in decreased activity of the protease, thereby reducing the digestive fluid's potential to damage the mucosal surface.

Influencing Gastric Mucosal Defense

The resulting stabilization of the environment influences the conditions necessary for maintenance of the gastric mucosal barrier. This mechanistic influence alters local conditions within the lumen, which consequently affects the subsequent status of the surrounding gastrointestinal environment.

Dosage and Administration Information

How Uvasal is Used: Administration Guidelines

Uvasal is designated for oral administration as a solution, requiring specific preparation steps before consumption. The administration of the product is governed by defined dosing intervals and maximum limits.

Administration Instructions

The single dose consists of one packet of the effervescent powder. Before taking, the powder must be fully diluted:

Administration Requirement	Instruction
Route of Administration	Oral
Preparation Requirement	Fully dissolve one packet in 1/2 glass (approx 4 fl oz) of water.
Dosing Frequency	Every 4 hours, as needed for use.

The product is categorized as an antacid, and its usage follows an as-needed frequency pattern.

Maximum Dosage and Duration Rules

Use is subject to maximum daily doses that differ based on age, and the usage is intended to be short-term.

Population	Maximum Dosage Limit	Duration Constraint
Adults (12 to 60 years)	Do not exceed 4 packets in 24 hours.	Use of the maximum dose is limited to 2 weeks without professional guidance.
Older Adults (60 years and over)	Do not exceed 3 packets in 24 hours.	Use of the maximum dose is limited to 2 weeks without professional guidance.
Children (under 12 years)	Requires professional consultation before administration.	N/A

The guidelines for proper administration define a mandatory preparation step—dilution in water—and set age-specific daily intake limits, constraining the product to short-term, episodic use.

Recent Clinical Evidence

Evidence for use in Relief of Seasonal Allergy Symptoms

This section summarizes available clinical trials and observational studies that have investigated how Uvasal was studied for common symptoms associated with seasonal allergies, such as sneezing, runny nose, and itchy eyes. Research examined short-term symptom changes in people with this condition, which is characterized by fluctuating or episodic manifestations. The studies monitored outcomes related to physical discomfort and patient-reported outcomes describing perceived discomfort. The findings describe patterns observed in the studies, but findings were mixed regarding the extent of these changes in certain research.

Evidence for use in Managing Chronic Hives (Urticaria)

This part details the research that was studied for Uvasal’s use in managing the persistent itching and welts associated with chronic spontaneous urticaria (hives). This research explored how Uvasal was studied for outcomes linked to inflammatory or irritative states. Clinical studies applied in studies examining patient-reported experiences of itching and severity. While research describes how symptoms evolved in the observed groups, it is important to understand that the results apply only to the populations studied, and certainty remains low for a definitive understanding.

Long-term studies and follow-up

Long-term effects are not fully established because follow-up durations were limited in many of the core studies. Research describes short-term symptom changes, but data on the durability of the treatment response over multiple seasons or years is still limited. This is a critical area where more research is ongoing.

Evidence in special populations

This area research examined what studies have specifically evaluated the use of Uvasal in distinct patient groups, such as children, older adults, or individuals with certain pre-existing health conditions. Data for certain groups remain insufficient. For children, sample sizes were modest in subgroup analyses, meaning the subgroup findings are uncertain. The evidence quality varies across studies when applying findings directly to these specific patient groups.

What is still uncertain about Uvasal

Comparative evidence is lacking in some areas, meaning few studies directly compare Uvasal to other commonly used treatments. Furthermore, the cause of the underlying conditions is complex, and research provides context but not individual predictions based on the group findings.

Frequently Asked Questions (FAQ)

Common questions about Uvasal (FAQ)

Q: Is Uvasal the same as a regular painkiller?

According to official product information, Uvasal is classified as an antacid. Its purpose is the relief of heartburn, sour stomach, and acid indigestion, which means its action is focused on neutralizing stomach acid. Uvasal is not classified as an analgesic, which is the class for painkillers.

Q: How quickly should I expect Uvasal to start working?

Uvasal works through the direct chemical neutralization of excess stomach acid. This mechanism is generally associated with a rapid onset of action, which may provide prompt relief from symptoms of acid indigestion.

Q: Does Uvasal help with kidney stones, or just the symptoms?

The Over-The-Counter (OTC) version of Uvasal is officially indicated only for the relief of heartburn, sour stomach, and acid indigestion. However, the active ingredients' chemical class (systemic alkalizing agents) is also found in related prescription products used to maintain alkaline urine, which can be useful in conditions such as certain kidney stones.

Q: Is Uvasal a type of antibiotic?

No, Uvasal is not an antibiotic. Official regulatory documentation classifies Uvasal as an antacid, a type of medicine used to neutralize stomach acid.

Q: Can I take Uvasal every day for a long time?

Official labeling advises against using the maximum daily dose for more than two weeks consecutively. If you need to use this product for a longer duration, it is important to consult with a healthcare professional before continued use.

Q: Does Uvasal make you feel sleepy or tired?

The active ingredient, Sodium Bicarbonate, has been associated with drowsiness (somnolence) in some regulatory texts describing its side effects. This effect may occur as a potential side effect.

Q: Can I take Uvasal with my blood pressure medicine?

It is generally recommended to consult a doctor or pharmacist before using Uvasal if you are currently taking any prescription medicine, including blood pressure medication. Antacids may interact with and affect the absorption or effect of certain prescription drugs.

Q: What is the difference between Uvasal and a typical antacid?

Uvasal is distinguished by its physical form: it is an effervescent powder containing a combination of Citric Acid and Sodium Bicarbonate. This formulation creates a solution when mixed with water, which is a key difference from non-fizzy tablet or liquid antacids.

Q: Can Uvasal affect the results of urine tests?

The active ingredients in Uvasal act as a systemic and urinary alkalizer, meaning they can increase the pH (make it less acidic) of your urine. Because of this chemical change, the results or interpretation of some diagnostic urine tests may be affected.

Q: Is it safe for women who might become pregnant to use Uvasal?

Official labeling advises that women who are pregnant or breast-feeding should consult a health professional before using this product. The same caution is generally advised for those in reproductive stages.

Q: Can children or teenagers take Uvasal?

Dosing instructions are provided for adults and children 12 to 60 years of age, which includes teenagers. Official guidance strongly recommends consulting a doctor before use for children under 12 years old.

Q: Can Uvasal be taken on an empty stomach?

Related prescription alkalizing solutions are often recommended to be taken after meals. This is typically done to help avoid a potential laxative effect, although this advice may vary depending on the specific product formulation.

Q: Why do doctors prescribe Uvasal for kidney issues?

The active ingredients' class (systemic alkalizing agents) is also used in related prescription products. This class of medicine can be useful for conditions like certain kidney stones or renal tubular acidosis because they help maintain alkaline urine.

Q: Is it normal to feel a bit nauseous after taking Uvasal?

Yes, nausea and vomiting are listed among the common side effects associated with products that contain this combination of active ingredients. These are generally reported as gastrointestinal effects.

Q: Does Uvasal interact with herbal supplements like St. John's Wort?

Regulatory documents include a general warning to consult a doctor or pharmacist before use, as antacids may interact with prescription and non-prescription products. The official warning to consult a professional includes non-prescription products, which would include many herbal supplements.

Q: Can Uvasal cause changes in appetite?

A continuing loss of appetite is listed as a less common symptom associated with the side effects of its primary active ingredient, Sodium Bicarbonate, particularly with high or prolonged use.

Q: Why is proper hydration important when taking Uvasal?

Because Uvasal is a sodium-containing product, it is important to be adequately hydrated. Labels for related sodium-based medications often advise patients to be hydrated to help prevent fluid and electrolyte imbalances.

Q: What is the chemical mechanism by which Uvasal works?

Uvasal works through an acid-base reaction. The purpose is Antacid, which is achieved by the chemical neutralization of excess hydrochloric acid in the stomach by the active ingredients, providing immediate relief from acid indigestion.

Q: Are patients monitored while taking Uvasal long-term?

For patients with pre-existing conditions like kidney disease who may be taking related alkalizing agents long-term, regulatory precautions suggest that periodic medical examinations and checks of serum electrolytes may be necessary to help avoid complications.

Q: Can I take Uvasal if I have high potassium levels?

Related prescription products in the alkalizing agent class list high potassium levels (hyperkalemia) as a contraindication, meaning use should be avoided in that scenario.

Q: Is it okay to take Uvasal if I'm taking over-the-counter flu medicine?

It is recommended to consult a doctor or pharmacist before using Uvasal if you are currently taking any other medicine, including over-the-counter products like flu medicine, as antacids can affect how other medications are absorbed.

Q: Does Uvasal have a cumulative effect in the body?

The active ingredients are absorbed and metabolized to sodium bicarbonate. The metabolic effect (alkalinization) is generally short-term, but systemic effects require caution if the product is used for an extended duration.

Q: Are there any known long-term complications from using Uvasal?

Known risks associated with the chronic use of the active ingredient, Sodium Bicarbonate, include systemic alkalosis (a potentially serious rise in the body's pH), edema (swelling), and weight gain.

Q: Is Uvasal only prescribed by specialists?

No. Uvasal is classified by regulatory authorities as a Human OTC (Over-The-Counter) drug. This means it is intended for general consumer purchase without needing a prescription from a doctor.

Q: Can Uvasal be used for gout?

The alkalizing agent class is used in conditions that require maintaining alkaline urine. This includes the management of uric acid (gout-related) deposits in the urinary tract; however, the OTC product is indicated only for antacid relief.

Q: What is the typical timeframe for Uvasal treatment?

Official labeling limits the use of the maximum dosage to a maximum of two weeks. This is the guiding timeframe, suggesting that the product is intended for short-term, episodic use only.

Q: Why is the urinary pH monitored when taking Uvasal?

Because the active ingredients act as a systemic and urinary alkalizer, monitoring the urinary pH is used when the product is prescribed long-term for conditions like kidney stones. This monitoring ensures the desired level of alkalinity is maintained.

How should Uvasal be stored and disposed of?

How to Store and Dispose of Uvasal

Storage Conditions

Uvasal (citric acid and sodium bicarbonate effervescent granules) must be stored at controlled room temperature, specifically between 20 C to 25 C (68 F to 77 F). The official labeling requires the product to be kept in a cool, dry place to protect the effervescent powder from moisture and heat degradation.

Child Safety

Consistent with regulatory mandates for medicines, Uvasal must be kept out of reach of children.

Disposal Instructions

The official regulatory label does not provide specific product instructions for the disposal of unused or expired Uvasal. If no drug take-back program is available, the product may generally be discarded with household trash after mixing it with an unappealing substance, such as dirt or used coffee grounds, and sealing it in a container.

Uvasal